Digital Tools and the NHS: How to Assess Risk and Reward

digital tools

Mayden will be joining Wysa, ORCHA, NHS England and CarefulAI on the 6th May at 2:45pm for a virtual panel discussion on how to ensure safety when deploying digital tools in NHS clinical settings.

The case for clinical digital tools in the NHS is clear. The benefits of health tech apps are proven to improve waiting time, reduce DNAs, provide better data insight and give higher patient engagement. The difficulty comes with careful selection from the wealth of choice available. With over 350,000 digital health apps on the market, and an average of 250 new health apps released every day, how can commissioners and clinical leads uphold safety standards while putting the best digital tools into the hands of clinicians and patients?

The panel of speakers will combine their wealth of knowledge to discuss what to look out for when investing in clinical digital tools, the requirements of DTAC accreditation and why it’s of benefit to both clinicians and digital health tool providers. The agenda includes implementation of standards, clinical safety, medical device licensing, assessment criteria and frameworks.

NHS commissioners and clinical leads are invited to join the webinar and submit any questions for the panel in advance. Secure your place here.

Introducing the speakers:

Fiona Dawson, Mayden
Fiona is Director here at Mayden, the company behind iaptus – the leading digital care record for psychological therapies in the UK. iaptus is used by more than 100 NHS organisations nationally, securely holding the records of over 6.5 million patients and supporting the care of 65% of patients referred to the NHS Improving Access to Psychological Therapies (IAPT) programme.

Liz Ashall-Payne, ORCHA
Liz is co-founder and CEO of ORCHA, the world’s leading provider of digital health accreditation and distribution services.

Rhod Joyce, NHS England
Rhod is Deputy Director of Innovation Development at NHS Transformation Directorate and was previously Head of Partnerships for NHSX.

Ross O’Brien, Wysa
Ross is Managing Director of Wysa UK, the world’s most advanced conversational AI for mental health. Prior to joining Wysa, Ross was previously Associate Director of Innovation and Technology at Central and North West London NHS Foundation Trust and Service Lead for the Grenfell Health and Wellbeing Service.

Joseph Connor, CarefulAI
Joseph is co-founder of CarefulAI, the world’s first AI assurance and validation systems firm.


This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our cookies information for more details.